-
WDNA Dashboard
- Holdings
WisdomTree BioRevolution Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
TWST Twist Bioscience Corporation | 85.39 k | 1.89 k shares | 3.44 | Common equity | Long | USA |
Novonesis (Novozymes) B
|
80.35 k | 1.11 k shares | 3.24 | Common equity | Long | Denmark |
NTRA Natera, Inc. | 69.44 k | 547.00 shares | 2.80 | Common equity | Long | USA |
State Street Navigator Securities Lending Government Money Market Portfolio | 64.00 k | 64.00 k shares | 2.58 | Short-term investment vehicle | Long | USA |
GERN Geron Corporation | 62.49 k | 13.76 k shares | 2.52 | Common equity | Long | USA |
LLY Eli Lilly and Company | 59.36 k | 67.00 shares | 2.39 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 56.25 k | 1.27 k shares | 2.27 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 55.78 k | 603.00 shares | 2.25 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 44.69 k | 1.31 k shares | 1.80 | Common equity | Long | USA |
VCEL Vericel Corporation | 43.98 k | 1.04 k shares | 1.77 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 43.83 k | 4.67 k shares | 1.77 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 40.49 k | 113.00 shares | 1.63 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 39.55 k | 712.00 shares | 1.59 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 39.33 k | 143.00 shares | 1.58 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 38.65 k | 1.52 k shares | 1.56 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 37.67 k | 81.00 shares | 1.52 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 37.22 k | 298.00 shares | 1.50 | Common equity | Long | USA |
DHR Danaher Corporation | 36.70 k | 132.00 shares | 1.48 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 36.51 k | 1.33 k shares | 1.47 | Common equity | Long | USA |
FATE Fate Therapeutics, Inc. | 36.39 k | 10.40 k shares | 1.47 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 35.74 k | 34.00 shares | 1.44 | Common equity | Long | USA |
CTLT Catalent, Inc. | 35.25 k | 582.00 shares | 1.42 | Common equity | Long | USA |
DD DuPont de Nemours, Inc. | 35.11 k | 394.00 shares | 1.41 | Common equity | Long | USA |
AMGN Amgen Inc. | 34.80 k | 108.00 shares | 1.40 | Common equity | Long | USA |
Novartis AG
|
34.78 k | 302.00 shares | 1.40 | Common equity | Long | Switzerland |
ZTS Zoetis Inc. | 31.46 k | 161.00 shares | 1.27 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 30.93 k | 50.00 shares | 1.25 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 30.77 k | 2.88 k shares | 1.24 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 30.18 k | 443.00 shares | 1.22 | Common equity | Long | USA |
A Agilent Technologies, Inc. | 30.14 k | 203.00 shares | 1.21 | Common equity | Long | USA |
Syensqo SA
|
29.68 k | 334.00 shares | 1.20 | Common equity | Long | Belgium |
AstraZeneca PLC
|
28.90 k | 371.00 shares | 1.16 | Common equity | Long | UK |
IONS Ionis Pharmaceuticals, Inc. | 28.80 k | 719.00 shares | 1.16 | Common equity | Long | USA |
TSN Tyson Foods, Inc. | 28.77 k | 483.00 shares | 1.16 | Common equity | Long | USA |
DOW Dow Inc. | 28.68 k | 525.00 shares | 1.16 | Common equity | Long | USA |
QIAGEN NV
|
28.39 k | 623.00 shares | 1.14 | Common equity | Long | Netherlands |
JNJ Johnson & Johnson | 28.36 k | 175.00 shares | 1.14 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 28.25 k | 337.00 shares | 1.14 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 28.05 k | 247.00 shares | 1.13 | Common equity | Long | USA |
BNTX BioNTech SE | 28.03 k | 236.00 shares | 1.13 | Common equity | Long | Germany |
LH Laboratory Corporation of America Holdings | 27.71 k | 124.00 shares | 1.12 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
27.53 k | 586.00 shares | 1.11 | Common equity | Long | Switzerland |
CTVA Corteva, Inc. | 27.45 k | 467.00 shares | 1.11 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 27.26 k | 2.22 k shares | 1.10 | Common equity | Long | USA |
Vitrolife AB
|
26.86 k | 1.07 k shares | 1.08 | Common equity | Long | Sweden |
NEO NeoGenomics, Inc. | 26.77 k | 1.82 k shares | 1.08 | Common equity | Long | USA |
DAR Darling Ingredients Inc. | 26.46 k | 712.00 shares | 1.07 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 26.29 k | 1.07 k shares | 1.06 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 26.08 k | 504.00 shares | 1.05 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 25.90 k | 324.00 shares | 1.04 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 25.65 k | 1.11 k shares | 1.03 | Common equity | Long | USA |
RGEN Repligen Corporation | 25.15 k | 169.00 shares | 1.01 | Common equity | Long | USA |
ILMN Illumina, Inc. | 24.91 k | 191.00 shares | 1.00 | Common equity | Long | USA |
Genmab A/S
|
24.28 k | 996.00 shares | 0.98 | Common equity | Long | Denmark |
Oxford Nanopore Technologies PLC
|
23.67 k | 11.09 k shares | 0.95 | Common equity | Long | UK |
Biohaven Ltd
|
23.19 k | 464.00 shares | 0.93 | Common equity | Long | Virgin Islands (British) |
Bayer AG
|
23.12 k | 683.00 shares | 0.93 | Common equity | Long | Germany |
Takeda Pharmaceutical Co Ltd
|
22.72 k | 792.00 shares | 0.92 | Common equity | Long | Japan |
PFE Pfizer Inc. | 21.56 k | 745.00 shares | 0.87 | Common equity | Long | USA |
BIO Bio-Rad Laboratories, Inc. | 21.41 k | 64.00 shares | 0.86 | Common equity | Long | USA |
ADM Archer-Daniels-Midland Company | 20.85 k | 349.00 shares | 0.84 | Common equity | Long | USA |
ORGN Origin Materials, Inc. | 19.97 k | 12.97 k shares | 0.80 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 19.26 k | 274.00 shares | 0.78 | Common equity | Long | USA |
BIIB Biogen Inc. | 19.00 k | 98.00 shares | 0.77 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 18.36 k | 948.00 shares | 0.74 | Common equity | Long | USA |
NTR Nutrien Ltd. | 18.36 k | 382.00 shares | 0.74 | Common equity | Long | Canada |
FMC FMC Corporation | 18.13 k | 275.00 shares | 0.73 | Common equity | Long | USA |
Lenzing AG
|
17.80 k | 448.00 shares | 0.72 | Common equity | Long | Austria |
SDGR Schrödinger, Inc. | 16.88 k | 910.00 shares | 0.68 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 16.71 k | 1.59 k shares | 0.67 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 15.82 k | 770.00 shares | 0.64 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 15.75 k | 5.62 k shares | 0.63 | Common equity | Long | USA |
BYND Beyond Meat, Inc. | 15.51 k | 2.29 k shares | 0.62 | Common equity | Long | USA |
Nufarm Ltd
|
15.49 k | 5.62 k shares | 0.62 | Common equity | Long | Australia |
Genus PLC
|
15.11 k | 562.00 shares | 0.61 | Common equity | Long | UK |
EDIT Editas Medicine, Inc. | 14.40 k | 4.22 k shares | 0.58 | Common equity | Long | USA |
GPRE Green Plains Inc. | 14.16 k | 1.05 k shares | 0.57 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 12.26 k | 543.00 shares | 0.49 | Common equity | Long | USA |
CRBU Caribou Biosciences, Inc. | 12.13 k | 6.19 k shares | 0.49 | Common equity | Long | USA |
MRNA Moderna, Inc. | 11.96 k | 179.00 shares | 0.48 | Common equity | Long | USA |
Verbio SE
|
11.67 k | 560.00 shares | 0.47 | Common equity | Long | Germany |
SANA Sana Biotechnology, Inc. | 10.95 k | 2.63 k shares | 0.44 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 10.37 k | 2.14 k shares | 0.42 | Common equity | Long | USA |
Takara Bio Inc
|
9.85 k | 1.40 k shares | 0.40 | Common equity | Long | Japan |
Solvay SA
|
9.00 k | 229.00 shares | 0.36 | Common equity | Long | Belgium |
CureVac NV
|
8.83 k | 3.00 k shares | 0.36 | Common equity | Long | Netherlands |
AGEN Agenus Inc. | 6.24 k | 1.14 k shares | 0.25 | Common equity | Long | USA |
ABSI Absci Corporation | 6.20 k | 1.62 k shares | 0.25 | Common equity | Long | USA |
Precigen Inc
|
5.75 k | 6.08 k shares | 0.23 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings, Inc. | 4.71 k | 578.00 shares | 0.19 | Common equity | Long | USA |
CFRXQ ContraFect Corporation | 4.28 k | 2.52 k shares | 0.17 | Common equity | Long | USA |
GRAL GRAIL, LLC | 426.56 | 31.00 shares | 0.02 | Common equity | Long | USA |